The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Antipsychotic drugs and obesity
Open accessAbstract
Mechanisms underlying antipsychotic cardiometabolic adverse effects are incompletely understood. This hampers the identification of high-risk patients, low-risk antipsychotics and preventive/ameliorative treatments. Recent clinical, molecular, and genetic data suggest that i) antipsychotic-naïve samples provide the greatest power for mechanistic studies; ii) weight and metabolic effects can be discordant, pointing to overlapping and distinct mechanisms; iii) antipsychotics affect satiety and energy homeostasis signaling; iv) the specific peptides mediating these effects are unknown but likely overlap with those involved in idiopathic obesity; and v) single nucleotide polymorphisms in genes encoding known neurotransmitter receptors and metabolic proteins are promising pharmacogenomic targets for countering adverse affects. However, sophisticated molecular studies and genome-wide association studies, ideally in antipsychotic-naïve/first episode samples, are needed to further advance the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050 · cited 14×
“These results are further supported by evidence of an interaction between histamine H1 and dopamine D2 blockade [47], genetic data [5,15,27,48–55], and by the fact that antipsychotics without relevant antihistaminergic activity, such as aripiprazole, amisulpride and haloperidol (Table 1), have clearly documented weigh…”
BackgroundMethodResultInfluentialSelf-citationThe physiology of brain histamine
Brown, R. E., Stevens, D. R., & Haas, H. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00039-3 · Cited by 988
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · cited 5×
“However, notwithstanding these unresolved questions, the potential for significant antipsychotic-related cardiometabolic effects has been established [3]; this risk differs across both FGAs and SGAs [3,6–11,32–34,61–63], and patients as well as behavioral factors are relevant [3–5].”
BackgroundInfluentialLeptin Receptor Signaling in Midbrain Dopamine Neurons Regulates Feeding
Hommel, J. D., Trinko, R., Sears, R. M., Georgescu, D., Liu, Z.-W., Gao, X.-B., Thurmon, J. J., Marinelli, M., & DiLeone, R. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.023 · Cited by 902
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Leptin Regulation of the Mesoaccumbens Dopamine Pathway
Fulton, S., Pissios, P., Manchon, R. P., Stiles, L., Frank, L., Pothos, E. N., Maratos-Flier, E., & Flier, J. S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.006 · Cited by 644
Half a century of antipsychotics and still a central role for dopamine D2 receptors
Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Thanos, P. K., Logan, J., Alexoff, D., Ding, Y.-S., Wong, C., Ma, Y., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.002 · Cited by 573
Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L., Ambler, D., Puglia, M., Maloney, A. E., Michael, E., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050756 · Cited by 478
Giskes, K., van Lenthe, F., Avendano‐Pabon, M., & Brug, J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00769.x · Cited by 478
Gersh, B. J., Sliwa, K., Mayosi, B. M., & Yusuf, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq030 · Cited by 465
Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
McEvoy, J. P., Lieberman, J. A., Perkins, D. O., Hamer, R. M., Gu, H., Lazarus, A., Sweitzer, D., Olexy, C., Weiden, P., & Strakowski, S. D. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1050 · Cited by 377
De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 362
Self-citationPharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Arranz, M. J., & de Leon, J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002009 · Cited by 351
Fleishhacker, W. W., Cetkovich-Bakmas, M., De Hert, M., Hennekens, C. H., Lambert, M., Leucht, S., Maj, M., McIntyre, R. S., Naber, D., Newcomer, J. W., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0401 · Cited by 328 · cited 1×
“Patients with severe mental disorders are at even higher risk than the general population for obesity, cardiometabolic risk factors, and related morbidity and mortality [2,3].”
BackgroundCorrell, C. U. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71701-6 · Cited by 273
Self-citationSimon, V., van Winkel, R., & De Hert, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04392 · Cited by 239
Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
Kane, J. M., & Correll, C. U. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06264yel · Cited by 232
Self-citationMaayan, L., Vakhrusheva, J., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.21 · Cited by 230
Self-citationRenström, F., Payne, F., Nordström, A., Brito, E. C., Rolandsson, O., Hallmans, G., Barroso, I., Nordström, P., Franks, P. W., & GIANT Consortium (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp041 · Cited by 226
Nielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.78 · Cited by 207
Self-citationInvolvement of Hypothalamic Histamine H1 Receptor in the Regulation of Feeding Rhythm and Obesity
Masaki, T., Chiba, S., Yasuda, T., Noguchi, H., Kakuma, T., Watanabe, T., Sakata, T., & Yoshimatsu, H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2250 · Cited by 203
Kane, J. M., Detke, H. C., Naber, D., Sethuraman, G., Lin, D. Y., Bergstrom, R. F., & McDonnell, D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.07081221 · Cited by 197
Weight effects associated with antipsychotics: A comprehensive database analysis
Parsons, B., Allison, D. B., Loebel, A., Williams, K., Giller, E., Romano, S., & Siu, C. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.025 · Cited by 191
McIntyre, R. S., & Jerrell, J. M. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.10.929 · Cited by 178
Kluge, M., Schuld, A., Himmerich, H., Dalal, M., Schacht, A., Wehmeier, P. M., Hinze-Selch, D., Kraus, T., Dittmann, R. W., & Pollmächer, T. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a8872 · Cited by 177
Gebhardt, S., Haberhausen, M., Heinzel-Gutenbrunner, M., Gebhardt, N., Remschmidt, H., Krieg, J.-C., Hebebrand, J., & Theisen, F. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.001 · Cited by 174
Patel, J. K., Buckley, P. F., Woolson, S., Hamer, R. M., McEvoy, J. P., Perkins, D. O., Lieberman, J. A., & for the CAFE investigators (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.025 · Cited by 169
Deng, C., Weston–Green, K., & Huang, X. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.009 · Cited by 166
Coccurello, R., & Moles, A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.008 · Cited by 163
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
Adkins, D. E., Åberg, K. A., McClay, J. L., Bukszár, J., Zhao, Z., Jia, P., Stroup, T. S., Perkins, D. O., McEvoy, J. P., Lieberman, J. A., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.14 · Cited by 159
Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
Jin, H., Meyer, J. M., Mudaliar, S. R. D., & Jeste, D. V. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.026 · Cited by 151
Management of antipsychotic-related weight gain
Maayan, L. A., & Correll, C. U. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.85 · Cited by 142
Self-citationHui, H., & Perfetti, R. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460129 · Cited by 137
Sentissi, O., Epelbaum, J., Olié, J., & Poirier, M. F. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm141 · Cited by 136
Strassnig, M., Miewald, J. M., Keshavan, M. S., & Ganguli, R. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.02.024 · Cited by 135
Thanos, P. K., Michaelides, M., Piyis, Y. K., Wang, G., & Volkow, N. D. (2008) · Synapse · doi:10.1002/syn.20468 · Cited by 135
Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis
Luca, V. D., Müller, D. J., de Bartolomeis, A., & Kennedy, J. L. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007547 · Cited by 119
Tiwari, A. K., Zai, C. C. H., Likhodi, O., Lisker, A., Singh, D., de Souza, R. P., Batra, P., Zaidi, S. H. E., Chen, S., Liu, F., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.235 · Cited by 108
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
Fountaine, R. J., Taylor, A. E., Mancuso, J. P., Greenway, F. L., Byerley, L. O., Smith, S. R., Most, M. M., & Fryburg, D. A. (2010) · Obesity · doi:10.1038/oby.2010.6 · Cited by 102
Pharmacogenetics of antipsychotic-induced weight gain
Correll, C. U., & Malhotra, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1949-9 · Cited by 94
Self-citationOlanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors
Kirk, S. L., Glazebrook, J., Grayson, B., Neill, J. C., & Reynolds, G. P. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1639-8 · Cited by 92
Pérez‐Iglesias, R., Vázquez‐Barquero, J. L., Amado, J., Berja, A., García‐Unzueta, M. T., Pelayo‐Terán, J. M., Carrasco-Marín, E., Mata, I. F., & Crespo‐Facorro, B. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b8e6 · Cited by 83
Lencz, T., Robinson, D. G., Napolitano, B. A., Sevy, S. M., Kane, J. M., Goldman, D. A., & Malhotra, A. K. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ca24b · Cited by 81
Self-citationObesity treatment: novel peripheral targets
Field, B. C. T., Chaudhri, O. B., & Bloom, S. R. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03522.x · Cited by 73
Pharmacogenetics of antipsychotic-induced side effects
Lencz, T., & Malhotra, A. K. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/tlencz · Cited by 72
Self-citationDavoodi, N., Kalinichev, M., Korneev, S. A., & Clifton, P. G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1415-1 · Cited by 68
Energy Expenditure and Physical Activity in Clozapine use: Implications for Weight Management
Sharpe, J.-K., STEDMAN, T. J., Byrne, N. M., Wishart, C., & Hills, A. P. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01888.x · Cited by 67
Allison, D. B., Loebel, A. D., Lombardo, I., Romano, S. J., & SIU, C. O. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.007 · Cited by 56
Hong, C., Liou, Y., Bai, Y. M., Chen, T.-T., Wang, Y.-C., & Tsai, S. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283397d06 · Cited by 53
Risperidone in the Management of Disruptive Behavior Disorders
Pandina, G., Aman, M. G., & Findling, R. L. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.379 · Cited by 52
Monteleone, P., Milano, W., Petrella, C., Canestrelli, B., & Maj, M. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e742c5 · Cited by 43
Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
de Souza, R. P., Luca, V. D., Muscettola, G., Rosa, D. V., de Bartolomeis, A., Romano‐Silva, M. A., & Kennedy, J. L. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.014 · Cited by 37
Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight
Bah, J., Westberg, L., Baghaei, F., Henningsson, S., Rosmond, R., Melke, J., Holm, G., & Eriksson, E. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.007 · Cited by 35
Theisen, F., Haberhausen, M., Firnges, M. A., Gregory, P., Reinders, J., Remschmidt, H., Hebebrand, J., & Antel, J. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500418 · Cited by 35
Wang, B., & Chehab, F. F. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.033 · Cited by 32
Stauffer, V. L., Lipkovich, I. A., Hoffmann, V. P., Heinloth, A. N., McGregor, H. S., & Kinon, B. J. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-12 · Cited by 25
Vimaleswaran, K. S., Zhao, J., Wainwright, N. W. J., Surtees, P. G., Wareham, N. J., & Loos, R. J. F. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.292 · Cited by 24
Correll, C. U., & Nielsen, J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01610.x · Cited by 21
Self-citationMolecular neuroendocrine targets for obesity therapy
de Kloet, A. D., & Woods, S. C. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833c3013 · Cited by 6
Pharmacogenomics in Psychiatry
Leckband, S. G., Bishop, J. R., & Ellingrod, V. L. (2007) · Journal of Pharmacy Practice · doi:10.1177/0897190007304824 · Cited by 2
Cited by
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Self-citationMetabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Olfson, M., Blanco, C., Wang, S., Laje, G., & Correll, C. U. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3074 · Cited by 449
Self-citationVancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., Probst, M., & De Hert, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050620 · Cited by 441
Self-citationCorrell, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1314 · Cited by 384
Metadata
- Authors
- Correll, C. U., Lencz, T., & Malhotra, A. K.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 17
- Issue
- 2
- Pages
- 97-107
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1973933734
- Cited by
- 307
- References
- 64
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.